Browse by Aston Author

2017

Tsatsakis, Aristidis M.; Nawaz, Muhammad Amjad; Tutelyan, Victor A.; Golokhvast, Kirill S.; Kalantzi, Olga-Ioanna; Chung, Duck Hwa; Kang, Sung Jo; Coleman, Michael D.; Tyshko, Nadia; Yang, Seung Hwan and Chung, Gyuhwa (2017). Impact on environment, ecosystem, diversity and health from culturing and using GMOs as feed and food. Food and Chemical Toxicology, 107 (part A), pp. 108-121.

2015

Tarczyluk, Marta A.; Nagel, David A.; Parri, H. Rhein; Tse, Erin H.Y.; Brown, James E.; Coleman, Michael D. and Hill, Eric J. (2015). Amyloid β 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks. Journal of Cerebral Bood Fow and Metabolism, 35 (8), pp. 1348-1357.

2014

Nagel, David A.; Hill, Eric J.; O'Neil, John; Mireur, Alexandra and Coleman, Michael D. (2014). The effects of the fungicides fenhexamid and myclobutanil on SH-SY5Y and U-251 MG human cell lines. Environmental Toxicology and Pharmacology, 38 (3), pp. 968-976.

Coleman, Michael D. (2014). Expert report writing in toxicology:forensic, scientific and legal aspects. Wiley-Blackwell.

2013

Tarczyluk, Marta A.; Nagel, David A.; O'Neil, John; Parri, H. Rheinallt; Tse, Erin H.Y.; Coleman, Michael D. and Hill, Eric J. (2013). Functional astrocyte-neuron lactate shuttle in a human stem cell-derived neuronal network. Journal of Cerebral Bood Fow and Metabolism, 33 (9), pp. 1386-1393.

2010

Coleman, Michael D. (2010). Human drug metabolism:an introduction. Wiley-Blackwell.

2008

Holden, Lindsay J. and Coleman, Michael D. (2008). Further preliminary assessment of three human glioma cell lines as models of human astrocytic toxicity in vitro. Environmental Toxicology and Pharmacology, 26 (3), pp. 290-296.

2007

Brown, Colin A.; Brown, Julia Y. and Coleman, Michael D. (2007). How drug metabolism influences treatment outcomes. Expert Opinion on Drug Metabolism and Toxicology, 3 (6), pp. 913-915.

Holden, Lindsay J. and Coleman, Michael D. (2007). Assessment of the astrogliotic responses of three human astrocytoma cell lines to ethanol, trimethyltin chloride and acrylamide. Toxicology, 241 (1-2), pp. 75-83.

Zilz, Thomas R.; Griffiths, Helen R. and Coleman, Michael D. (2007). Apoptotic and necrotic effects of hexanedione derivatives on the human neuroblastoma line SK-N-SH. Toxicology, 231 (2-3), pp. 210-214.

Coleman, Michael D.; Rimmer, Georgina S.E. and Haenen, Guido R.M.M. (2007). Effects of lipoic acid and dihydrolipoic acid on total erythrocytic thiols under conditions of restricted glucose in vitro. Basic and Clinical Pharmacology and Toxicology, 100 (2), pp. 139-144.

2006

Woehrling, Elizabeth K.; Zilz, Thomas R. and Coleman, Michael D. (2006). The toxicity of hexanedione isomers in neural and astrocytic cell lines. Environmental Toxicology and Pharmacology, 22 (3), pp. 249-254.

Coleman, Michael D.; Williams, Charlotte and Haenen, Guido R.M.M. (2006). Effects of lipoic acid and dihydrolipoic acid on 4-aminophenol-mediated erythrocytic toxicity in vitro. Basic and Clinical Pharmacology and Toxicology, 99 (3), pp. 225-229.

Rathbone, Daniel L.; Parker, Katy J.; Coleman, Michael D.; Lambert, Peter A. and Billington, David C. (2006). Discovery of a potent phenolic N1-benzylidene- pyridinecarboxamidrazone selective against Gram-positive bacteria. Bioorganic and Medicinal Chemistry Letters, 16 (4), pp. 879-883.

Coleman, Michael D. (2006). Progress in the development of in vitro human-based alternatives to animal models. Environmental Toxicology and Pharmacology, 21 (2), pp. 120-122.

2004

Coleman, Michael D.; Khan, Nazish; Welton, Graham; Lambert, Peter A.; Tims, Katy J. and Rathbone, Daniel L. (2004). Effects of glutathione, N-acetyl-cysteine, α-lipoic acid and dihydrolipoic acid on the cytotoxicity of a 2-pyridylcarboxamidrazone antimycobacterial agent in human mononuclear leucocytes in vitro. Environmental Toxicology and Pharmacology, 17 (3), pp. 143-148.

2003

Coleman, Michael D.; Khalaf, Laila F. and Nicholls, Paul J. (2003). Aminoglutethimide-induced leucopenia in a mouse model:effects of metabolic and structural determinates. Environmental Toxicology and Pharmacology, 15 (1), pp. 27-32.

2001

Coleman, Michael D.; Rathbone, Daniel L.; Chima, Rajinda; Lambert, Peter A. and Billington, David C. (2001). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology, 9 (3), pp. 99-102.

2000

Coleman, Michael D.; Rathbone, Daniel L.; Tims, Katie J.; Chima, Rajinda; Hovey, Melanie C.; Endersby, Catrina; Lee, Abberley and Billington, David C. (2000). Predictive toxicity studies on a set of antimycobacterial N′-benzylidene-heteroarylcarboxamidrazones. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 292.